3157Nombre de vues
13Évaluation

Dymista® is a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate. The recommended daily dose is one spray in each nostril twice a day (morning and evening). More effective than current first line therapy in reducing both nasal and ocular symptoms.